Skip to main content
Top
Published in: Virchows Archiv 2/2023

Open Access 06-07-2023 | Original Article

High-grade non-intestinal type sinonasal adenocarcinoma with ETV6::NTRK3 fusion, distinct from secretory carcinoma by immunoprofile and morphology

Authors: Natálie Klubíčková, Elaheh Mosaieby, Nikola Ptáková, Aude Trinquet, Marick Laé, Valérie Costes-Martineau, Alena Skálová

Published in: Virchows Archiv | Issue 2/2023

Login to get access

Abstract

We report 2 cases of high-grade sinonasal adenocarcinoma with a distinct morphological and immunohistochemical phenotype. Albeit histologically different from secretory carcinoma of the salivary glands, both tumors presented here share an ETV6::NTRK3 fusion. The highly cellular tumors were composed of solid and dense cribriform nests, often with comedo-like necroses in the center, and minor areas with papillary, microcystic, and trabecular formations without secretions, mostly located at the periphery of the lesion. The cells displayed high-grade features, with enlarged, crowded, and often vesicular nuclei with conspicuous nucleoli and brisk mitotic activity. The tumor cells were immunonegative for mammaglobin while showing immunopositivity for p40/p63, S100, SOX10, and GATA3, as well as for cytokeratins 7, 18, and 19. For the first time, we describe 2 cases of primary high-grade non-intestinal type adenocarcinomas of the nasal cavity, distinct from secretory carcinoma by morphology and immunoprofile, harboring the ETV6::NTRK3 fusion.
Literature
1.
go back to reference Thompson LDR, Loney EL, Bishop JA et al (2022) Chapter 2: Nasal, paranasal, and skull base tumours. In: WHO Classification of Tumours Editorial Board. Head and neck tumours. [Internet; beta version ahead of print]. International Agency for Research on Cancer, Lyon (France) [cited 2023 May 8]. (WHO classification of tumours series, 5th ed.; vol. 9). Available from: https://tumourclassification.iarc.who.int/chapters/52/1 Thompson LDR, Loney EL, Bishop JA et al (2022) Chapter 2: Nasal, paranasal, and skull base tumours. In: WHO Classification of Tumours Editorial Board. Head and neck tumours. [Internet; beta version ahead of print]. International Agency for Research on Cancer, Lyon (France) [cited 2023 May 8]. (WHO classification of tumours series, 5th ed.; vol. 9). Available from: https://​tumourclassifica​tion.​iarc.​who.​int/​chapters/​52/​1
4.
go back to reference Dogan S, Chute DJ, Xu B et al (2017) Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas. J Pathol 242(4):400–408CrossRefPubMedPubMedCentral Dogan S, Chute DJ, Xu B et al (2017) Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas. J Pathol 242(4):400–408CrossRefPubMedPubMedCentral
5.
go back to reference Mito JK, Bishop JA, Sadow PM et al (2018) Immunohistochemical detection and molecular characterization of IDH-mutant sinonasal undifferentiated carcinomas. Am J Surg Pathol 42(8):1067–1075CrossRefPubMed Mito JK, Bishop JA, Sadow PM et al (2018) Immunohistochemical detection and molecular characterization of IDH-mutant sinonasal undifferentiated carcinomas. Am J Surg Pathol 42(8):1067–1075CrossRefPubMed
6.
go back to reference Leivo I (2007) Update on sinonasal adenocarcinoma: classification and advances in immunophenotype and molecular genetic make-up. Head Neck Pathol 1(1):38–43CrossRefPubMedPubMedCentral Leivo I (2007) Update on sinonasal adenocarcinoma: classification and advances in immunophenotype and molecular genetic make-up. Head Neck Pathol 1(1):38–43CrossRefPubMedPubMedCentral
7.
go back to reference Brayer KJ, Frerich CA, Kang H, Ness SA (2016) Recurrent fusions in MYB and MYBL1 define a common, transcription factor-driven oncogenic pathway in salivary gland adenoid cystic carcinoma. Cancer Discov 6(2):176–187CrossRefPubMed Brayer KJ, Frerich CA, Kang H, Ness SA (2016) Recurrent fusions in MYB and MYBL1 define a common, transcription factor-driven oncogenic pathway in salivary gland adenoid cystic carcinoma. Cancer Discov 6(2):176–187CrossRefPubMed
8.
go back to reference Mitani Y, Liu B, Rao PH et al (2016) Novel MYBL1 gene rearrangements with recurrent MYBL1-NFIB fusions in salivary adenoid cystic carcinomas lacking t(6;9) translocations. Clin Cancer Res 22(3):725–733CrossRefPubMed Mitani Y, Liu B, Rao PH et al (2016) Novel MYBL1 gene rearrangements with recurrent MYBL1-NFIB fusions in salivary adenoid cystic carcinomas lacking t(6;9) translocations. Clin Cancer Res 22(3):725–733CrossRefPubMed
9.
go back to reference Okumura Y, Nakano S, Murase T et al (2020) Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: a multiinstitutional retrospective study. Cancer Sci 111(11):4195–4204CrossRefPubMedPubMedCentral Okumura Y, Nakano S, Murase T et al (2020) Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: a multiinstitutional retrospective study. Cancer Sci 111(11):4195–4204CrossRefPubMedPubMedCentral
10.
go back to reference Haller F, Bieg M, Will R et al (2019) Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands. Nat Commun 10(1):368CrossRefPubMedPubMedCentral Haller F, Bieg M, Will R et al (2019) Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands. Nat Commun 10(1):368CrossRefPubMedPubMedCentral
11.
go back to reference Skálová A, Vanecek T, Sima R et al (2010) Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 34(5):599–608CrossRefPubMed Skálová A, Vanecek T, Sima R et al (2010) Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 34(5):599–608CrossRefPubMed
12.
go back to reference Baneckova M, Agaimy A, Andreasen S et al (2018) Mammary analog secretory carcinoma of the nasal cavity: characterization of 2 cases and their distinction from other low-grade sinonasal adenocarcinomas. Am J Surg Pathol 42(6):735–743CrossRefPubMed Baneckova M, Agaimy A, Andreasen S et al (2018) Mammary analog secretory carcinoma of the nasal cavity: characterization of 2 cases and their distinction from other low-grade sinonasal adenocarcinomas. Am J Surg Pathol 42(6):735–743CrossRefPubMed
13.
go back to reference Skálová A, Vanecek T, Majewska H et al (2014) Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes. Am J Surg Pathol 38(1):23–33CrossRefPubMed Skálová A, Vanecek T, Majewska H et al (2014) Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes. Am J Surg Pathol 38(1):23–33CrossRefPubMed
14.
go back to reference Skalova A, Leivo I, Hellquist H et al (2021) High-grade transformation/dedifferentiation in salivary gland carcinomas: occurrence across subtypes and clinical significance. Adv Anat Pathol 28(3):107–118CrossRefPubMed Skalova A, Leivo I, Hellquist H et al (2021) High-grade transformation/dedifferentiation in salivary gland carcinomas: occurrence across subtypes and clinical significance. Adv Anat Pathol 28(3):107–118CrossRefPubMed
15.
go back to reference Andreasen S, Skálová A, Agaimy A et al (2017) ETV6 gene rearrangements characterize a morphologically distinct subset of sinonasal low-grade non-intestinal-type adenocarcinoma: a novel translocation-associated carcinoma restricted to the cinonasal tract. Am J Surg Pathol 41(11):1552–1560CrossRefPubMed Andreasen S, Skálová A, Agaimy A et al (2017) ETV6 gene rearrangements characterize a morphologically distinct subset of sinonasal low-grade non-intestinal-type adenocarcinoma: a novel translocation-associated carcinoma restricted to the cinonasal tract. Am J Surg Pathol 41(11):1552–1560CrossRefPubMed
16.
go back to reference Rooper LM, Thompson LDR, Gagan J et al (2022) Low-grade non-intestinal-type sinonasal adenocarcinoma: a histologically distinctive but molecularly heterogeneous entity. Mod Pathol 35(9):1160–1167CrossRefPubMed Rooper LM, Thompson LDR, Gagan J et al (2022) Low-grade non-intestinal-type sinonasal adenocarcinoma: a histologically distinctive but molecularly heterogeneous entity. Mod Pathol 35(9):1160–1167CrossRefPubMed
17.
go back to reference Andreasen S, Kiss K, Melchior LC, Laco J (2018) The ETV6-RET gene fusion is found in ETV6-rearranged low-grade sinonasal adenocarcinoma without NTRK3 involvement. Am J Surg Pathol 42(7):985–988CrossRefPubMed Andreasen S, Kiss K, Melchior LC, Laco J (2018) The ETV6-RET gene fusion is found in ETV6-rearranged low-grade sinonasal adenocarcinoma without NTRK3 involvement. Am J Surg Pathol 42(7):985–988CrossRefPubMed
18.
go back to reference Kishikawa S, Hayashi T, Shimizu J et al (2022) Low-grade tracheal adenocarcinoma with ETV6::NTRK3 fusion: unique morphology akin to subsets of sinonasal low-grade non-intestinal-type adenocarcinoma. Virchows Arch 481(5):793–797CrossRefPubMed Kishikawa S, Hayashi T, Shimizu J et al (2022) Low-grade tracheal adenocarcinoma with ETV6::NTRK3 fusion: unique morphology akin to subsets of sinonasal low-grade non-intestinal-type adenocarcinoma. Virchows Arch 481(5):793–797CrossRefPubMed
19.
go back to reference Rupp NJ, Nemes C, Rushing EJ, Huber GF, Freiberger SN (2021) High-grade salivary gland adenocarcinoma harboring ETV6-NTRK3 fusion: defined by morphology or molecular aberration? Head Neck Pathol 15(3):1082–1084CrossRefPubMedPubMedCentral Rupp NJ, Nemes C, Rushing EJ, Huber GF, Freiberger SN (2021) High-grade salivary gland adenocarcinoma harboring ETV6-NTRK3 fusion: defined by morphology or molecular aberration? Head Neck Pathol 15(3):1082–1084CrossRefPubMedPubMedCentral
20.
21.
go back to reference Lanic MD, Guérin R, Wassef M, et al (2023) Detection of salivary gland and sinonasal fusions by a next-generation sequencing based, ligation-dependent, multiplex RT-PCR assay [published online ahead of print, 2023 Jun 22]. Histopathology. https://doi.org/10.1111/his.14971 Lanic MD, Guérin R, Wassef M, et al (2023) Detection of salivary gland and sinonasal fusions by a next-generation sequencing based, ligation-dependent, multiplex RT-PCR assay [published online ahead of print, 2023 Jun 22]. Histopathology. https://​doi.​org/​10.​1111/​his.​14971
22.
go back to reference Purgina B, Bastaki JM, Duvvuri U, Seethala RR (2015) A subset of sinonasal non-intestinal type adenocarcinomas are truly seromucinous adenocarcinomas: a morphologic and immunophenotypic assessment and description of a novel pitfall. Head Neck Pathol 9(4):436–446CrossRefPubMedPubMedCentral Purgina B, Bastaki JM, Duvvuri U, Seethala RR (2015) A subset of sinonasal non-intestinal type adenocarcinomas are truly seromucinous adenocarcinomas: a morphologic and immunophenotypic assessment and description of a novel pitfall. Head Neck Pathol 9(4):436–446CrossRefPubMedPubMedCentral
23.
go back to reference Stelow EB, Jo VY, Mills SE, Carlson DL (2011) A histologic and immunohistochemical study describing the diversity of tumors classified as sinonasal high-grade nonintestinal adenocarcinomas. Am J Surg Pathol 35(7):971–980CrossRefPubMed Stelow EB, Jo VY, Mills SE, Carlson DL (2011) A histologic and immunohistochemical study describing the diversity of tumors classified as sinonasal high-grade nonintestinal adenocarcinomas. Am J Surg Pathol 35(7):971–980CrossRefPubMed
Metadata
Title
High-grade non-intestinal type sinonasal adenocarcinoma with ETV6::NTRK3 fusion, distinct from secretory carcinoma by immunoprofile and morphology
Authors
Natálie Klubíčková
Elaheh Mosaieby
Nikola Ptáková
Aude Trinquet
Marick Laé
Valérie Costes-Martineau
Alena Skálová
Publication date
06-07-2023
Publisher
Springer Berlin Heidelberg
Published in
Virchows Archiv / Issue 2/2023
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-023-03587-6

Other articles of this Issue 2/2023

Virchows Archiv 2/2023 Go to the issue